EMA EMA sets out process to appoint next Executive Director EMA’s September Management Board meeting advanced the process for appointing its next Executive Director while reviewing preparations for new EU pharmaceutical legislation
EMA EMA backs 12 new medicines, alongside key label expansions The EMA’s CHMP recommended 12 new medicines for approval and 11 indication extensions at its September 2026 meeting
Inside EU Health Inside EU Health: Women’s health; digital; Ebola; Marburg; hantavirus 'Now is really the time!' for women's health, says Cooke; Macron and WHO chief back stronger safeguards for children online; Ebola outbreak expands and WHO condemns attacks on health facilities; WHO declares cruise ship hantavirus outbreak over
EMA EMA recommends three new medicines and an orphan treatment for rare Rett Syndrome EMA’s human medicines committee (CHMP) recommended six medicines for approval at its June 2026 meeting
Inside EU Health Inside EU Health: Anti-dumping; Ebola; hantavirus; EMA recommendations Sandoz says situation has reached ‘breaking point’; WHO risk assessment raises DRC to ‘very high’; further hantavirus positive test in Spain; EMA recommends eight new medicines for approval
EMA EMA recommends eight new medicines for approval The European Medicines Agency’s Committee for Medicinal Products for Human recommends eight new medicines for approval, alongside 13 extensions of indication for existing medicines.
Inside EU Health Inside EU Health: EMA vaccine confidence group; limits on vapes; liver health crisis EMA steps up vaccine misinformation fight; Europe’s liver health crisis demands urgent action
Medical devices EMA pilot to fast-track breakthrough medical devices The European Medicines Agency has launched a new pilot programme aimed at accelerating the development of “breakthrough” medical devices
Inside EU Health Inside EU Health: UK Biobank suspended; France chooses ‘sovereign’ cloud for health data; latest EMA medicines approvals UK Biobank suspends access following Alibaba revelations; France chooses ‘sovereign’ cloud for health data; EMA recommends five new medicines, including a first-in-class small interfering RNA treatment
EMA EMA recommends five new medicines, including a first-in-class small interfering RNA treatment Five new medicines are recommended for approval; a further nine medicines are recommended for extension of their therapeutic indications
EMA EMA recommends five new medicines addressing rare diseases and aggressive cancers The European Medicines Agency recommends five new therapies, including breakthrough treatments for small cell lung cancer and rare immune disorders, marking progress in areas of high unmet medical need
Inside EU Health Inside EU Health: Tariff chaos, court setback on Urban Wastewater for pharma; EMA starts its search for a new Executive Director ‘Tariff chaos’ but pharmaceuticals may stay outside the fray; industry groups continue to fight Wastewater Treatment Directive despite court setback; EMA starts its search for a new Executive Director
Inside EU Health Inside EU Health: CMA trilogue; cardiovascular strategy; EMA medicines approval; healthcare accessibility Critical Medicines Act negotiations begin; prevention takes centre stage in opening EU cardiovascular health report; EMA recommends approval of six medicines, expands indications for nine; Eurostat figures show wide gaps in healthcare accessibility across EU
EMA EMA recommends approval of six medicines, expands indications for nine EMA recommended six medicines for approval at its meeting and extended the therapeutic indications of nine medicines.
Inside EU Health Inside EU Health: Parliament votes on Critical Medicines Act; EMA regulatory co-operation; Paracetamol (still) safe during pregnancy Parliament votes on Critical Medicines Act position; EMA to build on regulatory co-operation piloted under COVID; Paracetamol is (still) safe during pregnancy
Inside EU Health Inside EU Health: US tariffs and MFN pricing threaten EU investment and access; EMA and FDA agree good AI; ECDC issues warning on Doxy-PEP Inside EU Health: US tariffs and MFN pricing threaten EU investment and access; EMA and FDA agree good AI principles; ECDC issues warning on Doxy-PEP
Medical devices EU moves to fix failing medical and in vitro device rules and spur innovation A 'targeted' revision to the MDR and IVDR promises clearer timelines, proportionate oversight and faster access to innovative technologies
Inside EU Health Inside EU Health: Pharma deal agreed; State of EU Health Report; WHO concludes that vaccines don’t cause autism - again The Council and Parliament reached a deal on the Pharma Package, the latest 'State of EU Health Report' is released, and WHO confirms - once again - that vaccines do not cause autism.
One Health Rising EU sales of animal antimicrobials raise concern The latest annual surveillance report from the European Medicines Agency (EMA) shows a worrying increase in antimicrobial sales for animal use across the European Union
Inside EU Health Inside EU Health: Europe not on track to meet AMR targets; US FDA and EMA will present a joint approach to AI; food industry fights back on ‘ultra-processed food’ Europe not on track to meet AMR targets; US FDA and EMA will present a joint approach to AI; food industry fights back on ‘ultra-processed food’
GLP-1 UK raid results in record haul of fraudulent weight-loss drugs The UK seizes record haul of fake weight-loss drugs worth over £250,000 amid rising online sales of counterfeit GLP-1 medicines
Inside EU Health Inside EU Health: Biotech Act(s); WHO preparedness; and study on drug spending dynamics Biotech Act(s); WHO preparedness; EMA consults on primates in research; and IQVIA study on drug spending dynamics
EMA EMA marks 30 years since first EU-wide medicine approval The European Medicines Agency reaffirms its mission to ensure safe, effective treatments across the EU
EMA EMA approves first treatment that addresses causes of serious chronic lung disease A new medicine to tackle non-cystic fibrosis bronchiectasis, offers new hope for patients with chronic lung disease
AMR WHO warns of alarming rise in antimicrobial resistance - Europe is not immune The WHO’s 2025 report on antimicrobial resistance warns of accelerating global threats and widening treatment gaps
